Drug Type Monoclonal antibody |
Synonyms MORAB 028, MORAB-028, MT 228 |
Target |
Action inhibitors |
Mechanism GD2 inhibitors(Disialoganglioside GD2 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Malignant melanoma, metastatic | Phase 1 | United States | 01 Dec 2010 | |
Metastatic melanoma | Phase 1 | United States | 01 May 2010 |